NASDAQ:PODD Insulet Q2 2026 Earnings Report $168.94 +1.47 (+0.88%) As of 10:34 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Insulet EPS ResultsActual EPSN/AConsensus EPS $1.45Beat/MissN/AOne Year Ago EPSN/AInsulet Revenue ResultsActual RevenueN/AExpected Revenue$787.42 millionBeat/MissN/AYoY Revenue GrowthN/AInsulet Announcement DetailsQuarterQ2 2026Date8/5/2026TimeBefore Market OpensConference Call DateWednesday, August 5, 2026Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Insulet Earnings HeadlinesPODD DEADLINE: Levi & Korsinsky Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline21 minutes ago | prnewswire.comINSULET CORPORATION INVESTORS WITH LOSSES HAVE UNTIL AUGUST 31, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline51 minutes ago | globenewswire.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.July 29 at 1:00 AM | Banyan Hill Publishing (Ad)PODD Court Deadline: Insulet Investor Deadline in Securities Fraud Class Action is August 31 – Contact BFA Law if You Lost Money4 hours ago | globenewswire.comPODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud LawsuitJuly 28 at 7:23 PM | prnewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers – PODDJuly 28 at 4:37 PM | globenewswire.comSee More Insulet Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Insulet? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Insulet and other key companies, straight to your email. Email Address About InsuletInsulet (NASDAQ:PODD) is a medical device company headquartered in Acton, Massachusetts, that develops, manufactures and sells insulin-delivery systems for people with diabetes. The company’s core business is the design and commercialization of its Omnipod family of tubeless, wearable insulin pumps and the consumable Pods that deliver insulin. Insulet’s products aim to simplify insulin delivery for people with type 1 diabetes and insulin-requiring type 2 diabetes by offering an alternative to traditional insulin pens and tethered pump systems. The company’s product portfolio includes the Omnipod System line—disposable, waterproof Pods that adhere to the skin and deliver insulin—and the associated controllers and mobile applications used to program and monitor insulin delivery. Insulet has advanced its platform to include systems with automated insulin delivery capabilities that integrate with continuous glucose monitoring (CGM) technologies to provide hybrid closed-loop functionality. In addition to hardware, the company offers related software, connectivity features and customer support services to enable remote monitoring and data sharing with caregivers and clinicians. Insulet operates in multiple international markets, with sales and distribution across North America, Europe, Asia-Pacific and other regions through direct channels and local partners. The company has positioned itself around innovation in tubeless pump technology, ongoing product development and regulatory engagement to expand indications and integrations. Insulet’s business model combines recurring revenues from disposable Pods and supplies with investments in research and development, manufacturing scale-up and commercial expansion to broaden access to its insulin-delivery solutions globally.View Insulet ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles These 3 Stocks Have Soared in 2026—Can They Keep Climbing?Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy StoryRambus: Another AI Phoenix Ready to Rise From the Ashes of CorrectionAmkor Sells Off After Earnings—Why Weak Guidance Isn't the Real StoryWestern Digital’s Earnings Will Test Whether Its AI Rally Has More RoomIs the Market Mispricing ServiceNow's AI Future?Whirlpool’s Report May Show How Frozen the Housing Market Really Is Upcoming Earnings Ferrari (7/30/2026)Air Products and Chemicals (7/30/2026)ArcelorMittal (7/30/2026)Vale (7/30/2026)Mastercard (7/30/2026)Apple (7/30/2026)ASE Technology (7/30/2026)Monolithic Power Systems (7/30/2026)CRH (7/30/2026)Quanta Services (7/30/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
